VERAPAMIL HYDROCHLORIDE
Generic: VERAPAMIL HYDROCHLORIDE
Chartwell RXManufacturer
ORALRoute
VERAPAMIL HYDROCHLORIDEActive Substance
1988-04-05Original Approval
VERAPAMIL HYDROCHLORIDE is FDA application ANDA071881, sponsored by HERITAGE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2024-07-02
Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial Cross contamination with other products.
Class III2024-07-02
Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial per carton, Rx Only, ManufacturCross contamination with other products.
Class II2021-03-15
Verapamil Hydrochloride Extended-Release Tablets USP 120 mg Rx Only NDC 68462-292-01 Manufactured by: Glenmark Generics CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class III2023-08-14
Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, ManufacturedSubpotent: Out of Specification for Assay Test at the 3-month time point.
Top Reported Reactions
1
DYSPNOEA
357 reports
2
NAUSEA
356 reports
3
DRUG INTERACTION
318 reports
4
DIZZINESS
299 reports
5
HYPOTENSION
293 reports
6
FATIGUE
279 reports
7
DIARRHOEA
273 reports
8
COMPLETED SUICIDE
247 reports
9
ABDOMINAL PAIN
246 reports
10
VOMITING
246 reports